Sakai Y[au] - Search Results

Year	Number of Results
1955	1
1958	1
1960	2
1961	4
1962	3
1963	4
1964	5
1965	5
1966	6
1967	4
1968	6
1969	8
1970	15
1971	18
1972	9
1973	15
1974	14
1975	5
1976	8
1977	5
1978	8
1979	17
1980	20
1981	25
1982	18
1983	35
1984	31
1985	18
1986	33
1987	25
1988	37
1989	63
1990	44
1991	49
1992	39
1993	40
1994	58
1995	45
1996	63
1997	55
1998	58
1999	76
2000	69
2001	87
2002	93
2003	91
2004	94
2005	94
2006	93
2007	114
2008	117
2009	117
2010	138
2011	139
2012	163
2013	169
2014	180
2015	177
2016	223
2017	230
2018	234
2019	249
2020	229
2021	176

1

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis.

Kakiuchi N, Yoshida K, Uchino M, Kihara T, Akaki K, Inoue Y, Kawada K, Nagayama S, Yokoyama A, Yamamoto S, Matsuura M, Horimatsu T, Hirano T, Goto N, Takeuchi Y, Ochi Y, Shiozawa Y, Kogure Y, Watatani Y, Fujii Y, Kim SK, Kon A, Kataoka K, Yoshizato T, Nakagawa MM, Yoda A, Nanya Y, Makishima H, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Sugihara E, Sato TA, Maruyama T, Miyoshi H, Taketo MM, Oishi J, Inagaki R, Ueda Y, Okamoto S, Okajima H, Sakai Y, Sakurai T, Haga H, Hirota S, Ikeuchi H, Nakase H, Marusawa H, Chiba T, Takeuchi O, Miyano S, Seno H, Ogawa S. Kakiuchi N, et al. Among authors: sakai y. Nature. 2020 Jan;577(7789):260-265. doi: 10.1038/s41586-019-1856-1. Epub 2019 Dec 18. Nature. 2020. PMID: 31853061

2

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer.

Mizuno R, Kawada K, Sakai Y. Mizuno R, et al. Among authors: sakai y. Int J Mol Sci. 2019 Dec 11;20(24):6254. doi: 10.3390/ijms20246254. Int J Mol Sci. 2019. PMID: 31835815 Free PMC article. Review.

3

Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.

Itatani Y, Kawada K, Sakai Y. Itatani Y, et al. Among authors: sakai y. Int J Mol Sci. 2019 Nov 20;20(23):5822. doi: 10.3390/ijms20235822. Int J Mol Sci. 2019. PMID: 31756952 Free PMC article. Review.

4

Age-related remodelling of oesophageal epithelia by mutated cancer drivers.

Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S. Yokoyama A, et al. Among authors: sakai y. Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2. Nature. 2019. PMID: 30602793

5

Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery.

Hoshino N, Takada T, Hida K, Hasegawa S, Furukawa TA, Sakai Y. Hoshino N, et al. Among authors: sakai y. Cochrane Database Syst Rev. 2020 Mar 25;3(3):CD012271. doi: 10.1002/14651858.CD012271.pub3. Cochrane Database Syst Rev. 2020. PMID: 32212387 Free PMC article. Review.

6

Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.

Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T. Maeda M, et al. Among authors: sakai y. Gut. 2020 Feb;69(2):243-251. doi: 10.1136/gutjnl-2018-317645. Epub 2019 May 13. Gut. 2020. PMID: 31085554

7

Assessment of body composition and impact of sarcopenia and sarcopenic obesity in patients with gastric cancer.

Nishigori T, Obama K, Sakai Y. Nishigori T, et al. Among authors: sakai y. Transl Gastroenterol Hepatol. 2020 Apr 5;5:22. doi: 10.21037/tgh.2019.10.13. eCollection 2020. Transl Gastroenterol Hepatol. 2020. PMID: 32258526 Free PMC article. Review.

8

A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs.

Igase M, Nemoto Y, Itamoto K, Tani K, Nakaichi M, Sakurai M, Sakai Y, Noguchi S, Kato M, Tsukui T, Mizuno T. Igase M, et al. Among authors: sakai y. Sci Rep. 2020 Oct 27;10(1):18311. doi: 10.1038/s41598-020-75533-4. Sci Rep. 2020. PMID: 33110170 Free PMC article.

9

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.

Xu L, Nagata N, Chen G, Nagashimada M, Zhuge F, Ni Y, Sakai Y, Kaneko S, Ota T. Xu L, et al. Among authors: sakai y. BMJ Open Diabetes Res Care. 2019 Oct 25;7(1):e000783. doi: 10.1136/bmjdrc-2019-000783. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31749970 Free PMC article.

10

Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis.

Ho TTB, Nasti A, Seki A, Komura T, Inui H, Kozaka T, Kitamura Y, Shiba K, Yamashita T, Yamashita T, Mizukoshi E, Kawaguchi K, Wada T, Honda M, Kaneko S, Sakai Y. Ho TTB, et al. Among authors: sakai y. J Immunother Cancer. 2020 Nov;8(2):e001367. doi: 10.1136/jitc-2020-001367. J Immunother Cancer. 2020. PMID: 33188035 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results